XTAI
4956
Market cap132mUSD
Oct 08, Last price
42.10TWD
1D
-1.64%
1Q
15.03%
Jan 2017
109.98%
IPO
40.33%
Name
Epileds Technologies Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Epileds Technologies, Inc., established in Tainan City, Taiwan, in 2006, is a global leader specializing in the comprehensive process of researching, developing, designing, manufacturing, and distributing LED wafers and chips. Their product portfolio encompasses a diverse range of light spectrums, including blue, green, red, and white LEDs. The company's offerings include AlGalnP LED chips, which operate within the 580 to 860nm wavelength range, and InGaN LED chips, providing light from 380 to 550nm. These advanced LED components are widely utilized across numerous industries and applications. They are integral to various lighting solutions such as landscape and plant illumination, general white light sources, and automotive systems including vehicle lighting and traffic signals. Additionally, Epileds' chips enhance display technologies, serving as indicators in consumer electronics, backlights for LCD monitors, and components for both indoor and outdoor display boards. Specialized applications extend to medical devices, CCTV systems, light sources for fax machines and scanners, high-voltage LED chips, and UV solutions, among others.
Key people
Meizhen Deng
Finance Manager · since 2006
Chris Chern
Director · since 2024
Director · since 2018
Deli Huang
Deputy General Manager, Director · since 2018
Director · since 2006
Jyh-Chau Wang
Director · since 2025
Mingsen Xu
Chairman of the Board, General Manager · since 2018
Zhenxun Zheng
Director · since 2021
Independent Director · since 2018
Yankun Su
Independent Director · since 2012
Independent Director · since 2021
Independent Director · since 2023
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||